+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Markets for Blood Plasma Products

  • ID: 4721221
  • Report
  • December 2018
  • Region: Global
  • 149 Pages
  • BCC Research
1 of 4

FEATURED COMPANIES

  • ADMA Biologics Inc.
  • Baxter International
  • Creat Group
  • General Electric Co.
  • Innovative Research
  • LFB Sa
  • MORE

Report Scope:

This research report presents an in-depth analysis of the global blood plasma market by product type, application, end user, and geographic market. In addition, the report provides qualitative information related to the mode of delivery for blood plasma.

The report includes key blood plasma products used in various therapeutic treatments as well as an examination of the supply chain from research to manufacturing. The report also features an in-depth analysis of key companies operating in the global blood plasma market and patents that highlight past, current and projected global technology trends. The blood plasma market is primarily segmented into five major blood plasma components: immunoglobulin, albumin, hyperimmune globulin, coagulation factor concentrates, and other plasma fractionation products. Immunoglobulins are further segmented into intravenous immunoglobulins, subcutaneous immunoglobulins and normal immunoglobulins such as immunoglobulin A (IgA), immunoglobin D (IgD), immunoglobin E (IgE), immunoglobin G (IgG), and immunoglobin M (ISM).

The global blood plasma market is further segmented by application, which helps in understanding the potency of blood plasma products in several therapeutic treatments. Immunology, oncology, pulmonology, rheumatology, transplant, neurology, hematology and other applications are explained in the report. Products based on these applications are explored in detail and their influence on R&D is examined. In the analysis based on end users, the blood plasma market is segmented as hospitals and clinics, research laboratories, academic institutions and blood transfusion centers.

In terms of geography, the report analyzes the market across North America, Europe, Asia-Pacific and the rest of the world (RoW). Key regions like the U.S., Canada, Mexico, Europe (U.K., Italy, France, Germany and Spain), China, India and Japan are highlighted in the discussion due to a high concentration of blood plasma products manufacturing companies and contract manufacturing organizations in these areas. This report includes estimates of market size using 2017 as the base year and forecasting forward to 2023. Recent products launched by blood plasma products companies are studied and listed in the report. The estimated values that are used are based on the manufacturers’ total revenues. The projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation.

A detailed analysis illustrating market dynamics and market structure is incorporated in the report. The market’s supply and distribution chain is discussed in detail in order to provide an in-depth understanding of the market. Top market players, along with details about their individual business operations and segment focus as well as analyses about their revenue and strategies, are included in the report. In addition, market share analysis of leading market players, product launches, and pipeline products are provided.

The Report Includes:

  • 52 data tables and 24 additional tables
  • Industry analysis of the global market for blood plasma products
  • Analyses of global market trends with data from 2017 to 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Quantification of the global blood plasma products markets by product, application, mode of delivery, end user and geographical region
  • Qualitative information related to mode of delivery for blood plasma
  • Key blood plasma products used in various therapeutic treatments as well as an examination of the supply chain from research to manufacturing
  • Coverage of segmentation of blood plasma products, including immunoglobulin, albumin, protease inhibitors, coagulation factor concentrates and other plasma fractionation products
  • In-depth analysis of the key strategies adopted by industry players, such as acquisition and geographical expansion
  • A look at major factors driving the growth of the global blood plasma products markets, including an organized network of donor centers and rising disease awareness and education
  • Profiles of the major players in the industry, including ADMA Biologics Inc., Baxter International Inc., Creat Group, Octapharma AG, Shire Plc and TCS Biosciences Ltd.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • ADMA Biologics Inc.
  • Baxter International
  • Creat Group
  • General Electric Co.
  • Innovative Research
  • LFB Sa
  • MORE

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Intended Audience
  • Geographic Breakdown
  • Analyst's Credentials
  • Custom Research
  • Related Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

  • Introduction to Blood Plasma Products
  • Components of Blood Plasma
  • Functions of Blood Plasma
  • Blood Donation
  • Collection and Extraction of Blood Plasma
  • Fractionation Methods for Extracting Individual Components from Plasma
  • Government Funding of Blood Donation Facilities
  • Government Regulations: FDA, International Regulatory Agencies and Medical Associations
  • Clinical Guidelines
  • Technology Trends
  • Market Dynamics
  • Drivers
  • Restraints
  • Opportunities

Chapter 4 Market Breakdown by Product Type

  • Overall Market Size and Forecast
  • Immunoglobulins
  • Market Size and Forecast by Region
  • Market Size and Forecast by Subsegment
  • Albumin
  • Market Size and Forecast by Region
  • Coagulation Factor Concentrates
  • Market Size and Forecast by Region
  • Hyperimmune Globulin
  • Market Size and Forecast by Region
  • Other Plasma Fractionation Products
  • Market Size and Forecast by Region

Chapter 5 Market Breakdown by Application

  • Overall Market Size and Forecast
  • Neurology
  • Market Size and Forecast by Region
  • Immunology
  • Market Size and Forecast by Region
  • Oncology
  • Market Size and Forecast by Region
  • Transplants
  • Market Size and Forecast by Region
  • Hematology
  • Market Size and Forecast by Region
  • Rheumatology
  • Market Size and Forecast by Region
  • Pulmonology
  • Market Size and Forecast by Region
  • Others
  • Market Size and Forecast by Region

Chapter 6 Market Breakdown by End User

  • Overall Market Size and Forecast
  • Hospitals and Clinics
  • Market Size and Forecast by Region
  • Research Laboratories
  • Market Size and Forecast by Region
  • Academic Institutions
  • Market Size and Forecast by Region
  • Blood Transfusion Centers
  • Market Size and Forecast by Region

Chapter 7 Mode of Delivery for Blood Plasma

  • Infusion Solutions
  • Gels
  • Sprays
  • Biomedical Sealants

Chapter 8 Market Breakdown by Region

  • Overall Market Size and Forecast by Region
  • North America
  • U.S. Market Size and Forecast
  • Canadian Market Size and Forecast
  • Mexican Market Size and Forecast
  • Market Size and Forecast by Product Type
  • Market Size and Forecast by Application
  • Market Size and Forecast by End User
  • Europe
  • German Market Size and Forecast
  • French Market Size and Forecast
  • Italian Market Size and Forecast
  • Spanish Market Size and Forecast
  • U.K. Market Size and Forecast
  • Rest of Europe Market Size and Forecast
  • Market Size and Forecast by Product Type
  • Market Size and Forecast by Application
  • Market Size and Forecast by End User
  • Asia-Pacific
  • Japanese Market Size and Forecast
  • Chinese Market Size and Forecast
  • Indian Market Size and Forecast
  • Australian Market Size and Forecast
  • South Korean Market Size and Forecast
  • Rest of Asia-Pacific Market Size and Forecast
  • Market Size and Forecast by Product Type
  • Market Size and Forecast by Application
  • Market Size and Forecast by End User
  • RoW
  • Latin American Market Size and Forecast
  • Middle Eastern Market Size and Forecast
  • African Market Size and Forecast
  • Other Countries Market Size and Forecast
  • Market Size and Forecast by Product Type
  • Market Size and Forecast by Application
  • Market Size and Forecast by End User

Chapter 9 Patent Review

Chapter 10 Competitive Landscape

  • Overview
  • Major Players and Market Shares
  • Porter’s Five Forces Analysis
  • Bargaining Power of Suppliers
  • Bargaining Power of Buyers
  • Threat of New Suppliers
  • Threat of Substitutes
  • Competitive Rivalry/Degree of Competition
  • Major Developments
  • Mergers and Acquisitions
  • New Product Launches and Product Approvals
  • Agreements, Collaborations Business Expansions, and Partnerships

Chapter 11 Company Profiles

  • ADMA BIOLOGICS INC.
  • Business Overview
  • Products and Services
  • Company Financials
  • Developments and Strategies
  • ARTHREX INC.
  • Business Overview
  • Products and Services
  • BAXTER INTERNATIONAL
  • Business Overview
  • Products and Services
  • Company Financials
  • CERUS CORP.
  • Business Overview
  • Products and Services
  • Company Financials
  • CHINA BIOLOGIC PRODUCTS INC.
  • Business Overview
  • Products and Services
  • Company Financials
  • Developments and Strategies
  • CSL LTD.
  • Business Overview
  • Products and Services
  • Company Financials
  • Developments and Strategies
  • CREAT GROUP
  • Business Overview
  • Products and Services
  • Developments and Strategies
  • GENERAL ELECTRIC CO.
  • GRIFOLS INTERNATIONAL SA
  • Business Overview
  • Products and Services
  • Company Financials
  • Developments and Strategies
  • INNOVATIVE RESEARCH
  • Business Overview
  • INTAS PHARMACEUTICALS LTD.
  • Business Overview
  • KEDRION SPA
  • Business Overview
  • Products and Services
  • Company Financials
  • Developments and Strategies
  • LFB SA
  • Business Overview
  • OCTAPHARMA AG
  • Business Overview
  • Products and Services
  • Company Financials
  • Developments and Strategies
  • PRIME BIOLOGICS PTE. LTD.
  • Business Overview
  • SANQUIN
  • Business Overview
  • SHANGHAI RAAS
  • Business Overview
  • SHIRE PLC
  • Business Overview
  • Products and Services
  • Company Financials
  • Developments and Strategies
  • TCS BIOSCIENCES LTD.

List of Tables
Summary Table: Global Market for Blood Plasma Products, by Region, Through 2023
Table 1: Blood Plasma Components
Table 2: Percentage of Major Proteins Present in Different Fractions After Cohn’s Fractionation Method
Table 3: Key Trends in the Global Blood Plasma Market
Table 4: Global Market for Blood Plasma, by Product Type, Through 2023
Table 5: Global Market for Immunoglobulins, by Region, Through 2023
Table 6: Global Market for Immunoglobulins, by Product Subsegment, Through 2023
Table 7: Global Market for Intravenous Immunoglobulin, by Region, Through 2023
Table 8: Global Market for Subcutaneous Immunoglobulins, by Region, Through 2023
Table 9: Global Market for Other Immunoglobulins, by Region, Through 2023
Table 10: Global Market for Albumins, by Region, Through 2023
Table 11: Global Market for Coagulation Factor Concentrates, by Region, Through 2023
Table 12: Global Market for Hyperimmune Globulins, by Region, Through 2023
Table 13: Protease Inhibitors Used in the Treatment of HIV
Table 14: Global Market for Other Plasma Fractionation Products, by Region, Through 2023
Table 15: Global Market for Blood Plasma Products, by Application, Through 2023
Table 16: Global Market for the Application of Blood Plasma Products in Neurology, by Region, Through 2023
Table 17: Global Market for the Application of Blood Plasma Products in Immunology, by Region, Through 2023
Table 18: Global Market for the Application of Blood Plasma Products in Oncology, by Region, Through 2023
Table 19: Global Market for the Application of Blood Plasma Products in Transplants, by Region, Through 2023
Table 20: Global Market for the Application of Blood Plasma Products in Hematology, by Region, Through 2023
Table 21: Global Market for the Application of Blood Plasma Products in Rheumatology, by Region, Through 2023
Table 22: Global Market for the Application of Blood Plasma Products in Pulmonology, by Region, Through 2023
Table 23: Global Market for the Application of Blood Plasma Products in Other Areas, by Region, Through 2023
Table 24: Global Market for Blood Plasma Products, by End User, Through 2023
Table 25: Global Market for Blood Plasma Products Used in Hospitals and Clinics, by Region, Through 2023
Table 26: Global Market for Blood Plasma Products Used in Research Laboratories, by Region, Through 2023
Table 27: Global Market for Blood Plasma Products Used in Academic Institutions, by Region, Through 2023
Table 28: Global Market for Blood Plasma Products Used in Blood Transfusion Centers, by Region, Through 2023
Table 29: Global Market for Blood Plasma Products, by Region, Through 2023
Table 30: North American Market for Blood Plasma Products, by Country, Through 2023
Table 31: Estimated New Cases of Cancer in the U.S., by Disease Type, 2017
Table 32: North American Market for Blood Plasma, by Product Type, Through 2023
Table 33: North American Market for Immunoglobulins, by Type, Through 2023
Table 34: North American Market for Blood Plasma Products, by Application, Through 2023
Table 35: North American Market for Blood Plasma Products, by End User, Through 2023
Table 36: European Market for Blood Plasma Products, by Country, Through 2023
Table 37: European Market for Blood Plasma, by Product Type, Through 2023
Table 38: European Market for Immunoglobulins, by Type, Through 2023
Table 39: European Market for Blood Plasma Products, by Application, Through 2023
Table 40: European Market for Blood Plasma Products, by End User, Through 2023
Table 41: Asia-Pacific Market for Blood Plasma Products, by Country, Through 2023
Table 42: Asia-Pacific Market for Blood Plasma, by Product Type, Through 2023
Table 43: Asia-Pacific Market for Immunoglobulins, by Type, Through 2023
Table 44: Asia-Pacific Market for Blood Plasma Products, by Application, Through 2023
Table 45: Asia-Pacific Market for Blood Plasma Products, by End User, Through 2023
Table 46: Rest of World Market for Blood Plasma Products, by Country, Through 2023
Table 47: Estimated Cases of Ebola Deaths in Africa, by Country, 2014-2016
Table 48: Rest of the World Market for Blood Plasma Products, by Product Type, Through 2023
Table 49: Rest of World Market for Immunoglobulins, by Type, Through 2023
Table 50: Rest of World Market for Blood Plasma Products, by Application, Through 2023
Table 51: Rest of World Market for Blood Plasma Products, by End User, Through 2023
Table 52: Patents Granted in North America, 2014-2017
Table 53: Patents Granted in Europe, 2014-2017
Table 54: Patents Granted in Asia-Pacific, 2014-2017
Table 55: Patents Granted in the RoW Region, 2014-2016
Table 56: Porter's Five Forces Analysis
Table 57: Mergers and Acquisitions
Table 58: New Product Launches and Product Approvals
Table 59: Agreements, Collaborations, Business Expansions and Partnerships
Table 60: ADMA Biologics Inc.: Product Portfolio
Table 61: ADMA Biologics Inc.: Developments and Strategies
Table 62: Cerus Corp.: Developments and Strategies
Table 63: China Biologic Products Inc.: Product Portfolio
Table 64: China Biologic Products Inc.: Developments and Strategies
Table 65: CSL Ltd.: Product Portfolio
Table 66: CSL Ltd.: Developments and Strategies
Table 67: Creat Group: Product Portfolio
Table 68: Creat Group: Developments and Strategies
Table 69: Grifols International SA: Product Portfolio
Table 70: Grifols International SA: Developments and Strategies
Table 71: Kedrion SpA: Developments and Strategies
Table 72: Octapharma AG: Product Portfolio
Table 73: Octapharma AG: Developments and Strategies
Table 74: Shire Plc: Product Portfolio
Table 75: Shire Plc: Developments and Strategies

List of Figures
Summary Figure: Global Market for Blood Plasma Products, by Region, 2017-2023
Figure 1: Role of Albumin Concentration in Maintaining Osmotic Pressure
Figure 2: Benefits of Blood Donation to the Donor
Figure 3: Distribution of Population Aged 65 and Above, by Region, 2015 and 2050
Figure 4: Blood Donation Globally, 2016 and 2017
Figure 5: FDA Regulation for Approval of Blood Products and Devices
Figure 6: Global Market for Blood Plasma, by Product Type, 2017-2023
Figure 7: Global Blood Plasma Market Share, by Product Type, 2017
Figure 8: Subsegments of the Market for Immunoglobulin Products
Figure 9: Global Immunoglobulins Market Share, by Region, 2017
Figure 10: Global Immunoglobulins Market Share, by Product Subsegment, 2017
Figure 11: Global Intravenous Immunoglobulin Market Share, by Region, 2017
Figure 12: Categorization of Subcutaneous Immunoglobulin
Figure 13: Global Subcutaneous Immunoglobulins Market Share, by Region, 2017
Figure 14: Global Market Share of Other Immunoglobulins, by Region, 2017
Figure 15: Global Albumins Market Share, by Region, 2017
Figure 16: Global Coagulation Factor Concentrates Market Share, by Region, 2017
Figure 17: Process of the Isolation of Hyperimmune Globulin
Figure 18: Global Hyperimmune Globulins Market Share, by Region, 2017
Figure 19: Global Market Share of Other Plasma Fractionation Products, by Region, 2017
Figure 20: Global Market for Blood Plasma Products, by Application, 2017-2023
Figure 21: Global Blood Plasma Products Market Share, by Application, 2017
Figure 22: The Study of Neurology
Figure 23: Role of Plasma Exchange in the Treatment of Neuroimmunological Disorders
Figure 24: Functions of the Immune System
Figure 25: Conditions Engendering Blood Transfusions
Figure 26: Categories of Bleeding Disorders
Figure 27: Symptoms of Lupus Infection
Figure 28: Global Market for Blood Plasma Products, by End User, 2017-2023
Figure 29: Global Blood Plasma Products Market Share, by End User, 2017
Figure 30: Role of Platelet-Rich Plasma in Treatment
Figure 31: Frequent Side Effects Associated with Immunoglobulin Infusions
Figure 32: Rarely Induced Severe Allergic Reactions Associated with Immunoglobulin Infusions
Figure 33: Procedure for Plasma Gel Treatment
Figure 34: Role of Fibrin Sealant in Coagulation Cascade
Figure 35: Global Market for Blood Plasma Products, by Region, 2017-2023
Figure 36: Global Blood Plasma Products Market Share, by Region, 2017
Figure 37: North American Market for Blood Plasma Products, by Country, 2017-2023
Figure 38: North American Blood Plasma Products Market Share, by Country, 2017
Figure 39: Distribution of Estimated New Cases of Cancer in the U.S., by Disease Type, 2017
Figure 40: U.S. Market for Blood Plasma Products, 2017-2023
Figure 41: Canadian Market for Blood Plasma Products, 2017-2023
Figure 42: Mexican Market for Blood Plasma Products, 2017-2023
Figure 43: European Market for Blood Plasma Products, by Country, 2017-2023
Figure 44: European Blood Plasma Products Market Share, by Country, 2017
Figure 45: German Market for Blood Plasma Products, 2017-2023
Figure 46: French Market for Blood Plasma Products, 2017-2023
Figure 47: Italian Market for Blood Plasma Products, 2017-2023
Figure 48: Spanish Market for Blood Plasma Products, 2017-2023
Figure 49: U.K. Market for Blood Plasma Products, 2017-2023
Figure 50: Rest of European Market for Blood Plasma Products, 2017-2023
Figure 51: Asia-Pacific Market for Blood Plasma Products, by Country, 2017-2023
Figure 52: Asia-Pacific Blood Plasma Products Market Share, by Country, 2017
Figure 53: Japanese Market for Blood Plasma Products, 2017-2023
Figure 54: Chinese Market for Blood Plasma Products, 2017-2023
Figure 55: Indian Market for Blood Plasma Products, 2017-2023
Figure 56: Australian Market for Blood Plasma Products, 2017-2023
Figure 57: South Korean Market for Blood Plasma Products, 2017-2023
Figure 58: Rest of Asia-Pacific Market for Blood Plasma Products, 2017-2023
Figure 59: Rest of World Market for Blood Plasma Products, by Country, 2017-2023
Figure 60: Rest of World Blood Plasma Products Market Share, by Country, 2017
Figure 61: Latin American Market for Blood Plasma Products, 2017-2023
Figure 62: Middle Eastern Market for Blood Plasma Products, 2017-2023
Figure 63: African Market for Blood Plasma Products, 2017-2023
Figure 64: Other Countries Market for Blood Plasma Products, 2017-2023
Figure 65: Global Market Share of Blood Plasma Products, by Company, 2017
Figure 66: Major Company Development Strategies, 2015-2018
Figure 67: ADMA Biologics Inc.: Financials, 2015-2017
Figure 68: ADMA Biologics Inc.: Revenue Share, by Segment, 2017
Figure 69: Baxter International: Financials, 2015-2017
Figure 70: Cerus Corp.: Financials, 2015-2017
Figure 71: China Biologic Products Inc.: Financials, 2015-2017
Figure 72: CSL Ltd.: Financials, 2015-2017
Figure 73: Grifols International SA: Financials, 2015-2017
Figure 74: Kedrion SpA: Financials, 2015-2017
Figure 75: Kedrion SpA: Revenue Share, by Segment, 2017
Figure 76: Octapharma AG: Financials, 2015-2017
Figure 77: Shire Plc: Financials, 2015-2017
Figure 78: Shire Plc: Revenue Share, by Segment, 2017

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • ADMA Biologics Inc.
  • Arthrex Inc.
  • Baxter International
  • Cerus Corp.
  • China Biologic Products Inc.
  • Creat Group
  • CSL Ltd.
  • General Electric Co.
  • Grifols International Sa
  • Innovative Research
  • Intas Pharmaceuticals Ltd.
  • Kedrion Spa
  • LFB Sa
  • Octapharma Ag
  • Prime Biologics Pte. Ltd.
  • Sanquin
  • Shanghai Raas
  • Shire Plc
  • TCS Biosciences Ltd.
Note: Product cover images may vary from those shown
Adroll
adroll